NOTE TO THE FILE
SERIAL NUMBER: 88579864
DATE: 11/18/2019
NAME: thardy
NOTE:
Searched:
Lexis/Nexis
OneLook
Wikipedia
Acronym Finder Protest evidence reviewed
Other:Checked:
Geographic significance
Surname
Translation
ID with ID/CLASS mailboxChecked list of approved Canadian attorneys and agents
Discussed file with
Attorney/Applicant via:
phone Left message with
email Attorney/ApplicantRequested Law Library search X Issued Examiner’s Amendment
for: and entered changes in TRADEUPSPRINT DO NOT PRINT Added design code in TRADEUPS
Description of the mark
Translation statement Re-imaged standard character
drawing
Negative translation statement
Consent of living individual Contacted TM MADRID ID/CLASS
about misclassified definite ID
Changed TRADEUPS to:X OTHER:
Hi Tarah.
We are ok with the below recommended changes. Please make these changes through examiner’s amendment and then approve the mark for publication. Thank you.
Regards,
Cathy Early-Warrington
___________________________________
Cathy Early-Warrington
Senior Paralegal
Cigna Legal
CIGNA Companies
1601 Chestnut StreetTwo Liberty Place, TL16G
Philadelphia, PA 19192(215) 761-6229
cathy.early-warrington@cigna.com
Confidential, unpublished property of Cigna. Do not duplicate or distribute. Use and distribution limited solely to authorized personnel. © Copyright 2019 Cigna.
From: Hardy, Tarah [mailto:Tarah.Hardy@USPTO.GOV]
Sent: Friday, November 15, 2019 2:09 PM
To: Larson, Troy E ESQ TL7LH <Troy.Larson@Cigna.com>
Cc: Early-Warrington, Cathy TL7LH <Cathy.Early-Warrington@Cigna.com>; Olson, ARKADIA D. (EHQ) <AOlson2@express-scripts.com>
Subject: [External] U.S. Trademark App. No. 88579864 - Informal Inquiry
Hello,
I am currently examining the trademark application for the mark EMBARC BENEFIT PROTECTION. No conflicting marks were found. However, before the mark can proceed to publication a few items need to be addressed.
1. The descriptive wording BENEFIT PROTECTION needs to be disclaimed.
2. The ID needs to be amended as indicated in bold below to comply with office format. I suggest the following if accurate:
Cost management for the healthcare, clinical and prescription drug benefit plans of others; medical cost management; business services, namely, prescription drug formulary cost management services; consulting services regarding healthcare and pharmacy cost management; healthcare utilization review services; organization and administration of networks of preferred healthcare providers, namely, arranging of managed care contractual services in the fields of health and medical services; cost management for the health care benefit plans of others; health care cost management services and healthcare utilization and review services; managed care services, namely, electronic processing of health care information, in International Class 35.
Pharmacy benefit management services; medical benefit management services; administration of pharmacy benefit plans concerning insurance and finance; organization and administration of networks of preferred healthcare provider plans; claims administration services in the field of health insurance; insurance administration in the field of health care; medical insurance case and utilization review and insurance claims adjustment services; administration of managed health care plans; insurance services, namely, administration of healthcare benefit insurance plans;
organization and administration of networks of preferred healthcare provider;[delete duplicate]; medical and pharmacy benefit management services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use, medical care, and healthcare habits, to identify potential cost savings and clinical benefits; underwriting and administration of health care benefit plans, in International Class 36.
I can make these changes through examiner’s amendment and then approve the mark for publication. Promptly let me know if this is acceptable.
Sincerely,
Tarah Hardy Ludlow
Trademark Attorney
USPTO - Law Office 110
571-272-9361
------------------------------------------------------------------------------
CONFIDENTIALITY NOTICE: If you have received this email in error,
please immediately notify the sender by e-mail at the address shown.
This email transmission may contain confidential information. This
information is intended only for the use of the individual(s) or entity to
whom it is intended even if addressed incorrectly. Please delete it from
your files if you are not the intended recipient. Thank you for your
compliance. Copyright (c) 2019 Cigna
==============================================================================